Methods of diagnosing and treating PARP-mediated diseases
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BIPAR SCI INC
- Publication Date
- 2011-03-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] Cross references to related applications
[0002] This application claims priority for US Provisional Application 61 / 026,077, filed on February 4, 2008, entitled "Methods for Diagnosing and Treating PARP-Mediated Diseases", which is incorporated herein by reference in its entirety. Background of the invention
[0003] The etiology of cancer and other diseases involves complex interactions between cytokines, including cellular enzyme receptors and other downstream intracellular factors that conduct signals through intracellular signaling networks. Growth factor receptors are considered to be important factors in cancer physiology, and they play an important role in the progression and maintenance of malignant phenotypes (Jones et al., 2006, Endocrine-Rel. Cancer, 13: S45-S51). For example, it has been shown that the expression of epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, is required for the formation of adenomas and tumors in bowel tumors, and the s...